Usefulness of 99mTc-tetrofosmin scintigraphy in different variants of Kaposi's sarcoma

Oncology

Volumn 65, Issue 4, 2003, Pages 295-305

  Spanu, A ^a   Madeddu, Gr ^a   Cottoni, F ^a   Manca, A ^a   Migaleddu, V ^a   Chessa, F ^a   Masala, M V ^a   Cossu, A ^a   Falchi, A ^a   Mura, M S ^a   Madeddu, G ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

99mTc tetrofosmin; Cutaneous lesions; Kaposi's sarcoma; Lymphadenopathy; Neck pinhole SPECT; SPECT

Indexed keywords

GALLIUM CITRATE GA 67; TETROFOSMIN TC 99M; CITRIC ACID; DIAGNOSTIC AGENT; GALLIUM; GALLIUM CITRATE; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER LOCALIZATION; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MALE; MUCOSA; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIODIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKIN MANIFESTATION; WHOLE BODY SCINTISCANNING; CANCER STAGING; DUODENUM TUMOR; LYMPH NODE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SKIN TUMOR; TONSIL TUMOR;

AGED; AGED, 80 AND OVER; CITRATES; DUODENAL NEOPLASMS; FEMALE; GALLIUM; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SARCOMA, KAPOSI; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TONSILLAR NEOPLASMS;

EID: 0347950043     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074642     Document Type: Article

References (64)

1. Bhana D, Templeton AC, Master SP, Kyalwazi SK: Kaposi sarcoma of lymph nodes. Br J Cancer 1970;24:646-470.
2. Ramos CV, Taylor HB, Hernandez BA, Tucker EF: Primary Kaposi's sarcoma of lymph nodes. Am J Clin Pathol 1976;66:998-1003.
3. Diebold J, Marche C, Audouin J, Aubert JP, Le Tourneau A, Bouton C, Reynes M, Wizniak J, Capron F, Tricottet V: Lymph node modification in patients with the acquired immunodeficiency syndrome (AIDS) or with AIDS-related complex (ARC). A histological, immuno-histopathological and ultrastructural study of 45 cases. Pathol Res Pract 1985;180:590-611.
4. Hofstetter SR, Stollman N: Adult intussusception in association with the acquired immune deficiency syndrome and intestinal Kaposi's sarcoma. Am J Gastroenterol 1988;83:1304-1305.
5. Levine AM, Tulpule A: Clinical aspects and management of AIDS-related Kaposi's sarcoma. Eur J Cancer 2001;37:1288-1295.
6. Lin CH, Hsu CW, Chiang YJ, Ng KF, Chiu CT: Esophageal and gastric Kaposi's sarcomas presenting as upper gastrointestinal bleeding. Chang Gung Med J 2002;25:329-333.
7. Garay SM, Balenko KO, Fazzini E, Schinella R: Pulmonary manifestation of Kaposi's sarcoma. Chest 1987;91:39-43.
8. Kaplan LD, Hopewell PC, Jaffe H, Goodman PC, Bottles K, Volberding PA: Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1988;1:23-30.
9. Khalil AM, Carette MF, Cadranel JL, Mayaud CM, Bigot JM: Intrathoracic Kaposi's sarcoma. CT findings. Chest 1995;108:1622-1626.
10. Aboulafia DM: The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma. Chest 2000;117:1128-1145.
11. Lee Morgan C, Gehweiler JA Jr: Kaposi's sarcoma in bone. A case report with unusual radiographic findings and an abnormal radioisotope scan. Rev Interam Radiol 1976;1:37-41.
12. Meyers SA, Kuhlman JE, Fishman EK: Kaposi sarcoma involving bone: CT demonstration in a patient with AIDS. J Comput Assist Tomogr 1990;14:161-162.
13. Ritz-Quillac L, Machet L, Machet MC, Vedere V, Vaillant L, Lorette G: Bone involvement in a case of Kaposi sarcoma. Dermatology 1999; 198:73-74.
14. Krauth PH, Katz JF: Kaposi's sarcoma involving the thyroid in a patient with AIDS. Clin Nucl Med 1987;11:848-849.
15. Stein ME, Spencer D, Ruff P: Lymphoproliferative malignancies in association with endemic African Kaposi's sarcoma. Cent Afr J Med 1994;40:176-178.
16. Serraino D, Franceschi S: Kaposi's sarcoma and non-Hodgkin's lymphomas in children and adolescents with AIDS. AIDS 1996;10:643-647.
17. Said JW, Tasaka T, Takeuchi S, Asou H, de Vos S, Cesarman E, Knowles DM, Koeffler HP: Primary effusion lymphoma in women: Report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996;88:3124-3128.
18. Hjalgrim H, Frisch M, Pukkala E, Tulinius H, Ekbom A, Dictor M, Langmark F, Hardarson S, Melbye M: Risk of second cancers in classical Kaposi's sarcoma. Int J Cancer 1997;73:840-843.
19. Beurey J, Weber M, Mazet J, De Ren G, Vaillant G: Association of Kaposi's sarcoma and Hodgkin's disease (in French). Ann Dermatol Syphiligr (Paris) 1976;103:151-159.
20. Nores JM, Dalayeun J, Raimond A, Nenna A: Association of Hodgkin's disease with Kaposi's sarcoma. Two case reports. Haematologica 1998;73:249-250.
21. Mitsuyasu RT, Colman MF, Sun NC: Simultaneous occurrence of Hodgkin's disease and Kaposi's sarcoma in a patient with the acquired immune deficiency syndrome. Am J Med 1986;80:954-958.
22. Bisceglia M, Zenarola P, Melillo L, Parisi S, Di Candia L, Carotenuto M: Cutaneous presentation of acute myeloid leukemia in a 'classical' Kaposi's sarcoma patient. Tumori 1990;76:400-402.
23. Baron JM, Pizarro A, Berrocal A, Contreras F, Casado M, Zamora P: Kaposi's sarcoma associated with chronic B lymphocytic leukemia. Coexistence of both diseases in skin lesions (in Spanish). Med Clin (Barc) 1991;96:700-702.
24. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-1869.
25. Gillison M, Ambinder RF: Human herpesvirus-8. Curr Opin Oncol 1997;9:440-449.
26. Antman K, Chang Y: Kaposi's sarcoma. N Engl J Med 2000;342:1027-1038.
27. Lee VW, Rosen MP, Baum A, Cohen SE, Cooley TP, Liebman HA: AIDS-related Kaposi sarcoma: Findings on thallium-201 scintigraphy. AJR Am J Roentgenol 1988;151:1233-1235.
28. Miller RF: Nuclear medicine and AIDS. Eur J Nucl Med 1990;16:103-118.
29. Rutman M, Rogow L, Roussis K: Radioisotope scanning of Kaposi's sarcoma: A modality for treatment planning. Cancer 1974;3:58-62.
30. Krishnamurty GT, Singhi V, Taylor RD, Ranganath K, Blahd WH: Radionuclide scanning in the evaluation of Kaposi sarcoma. Arch Intern Med 1976;136:400-403.
31. Madeddu G, Borroni G, Rabbiosi G, Campus S: Scintigraphic evaluation of Kaposi's sarcoma. Dermatologica 1978;156:332-340.
32. Madeddu G, Cottoni F, Casu AR, Canalis GC: Radioisotope scanning in Kaposi's sarcoma. Ital Gen Rev Derm 1980;1-2:57-68.
33. Lee VW, Chen H, Panageas E, O'Keane JC, Liebman HA: Subcutaneous Kaposi's sarcoma. Thallium scan demonstration. Clin Nucl Med 1990;15:569-571.
34. Abdel-Dayem HM, Di Fabrizio L, Kowalsky W, Aras T, Sadik A, Kempf J, Habbab MN, Pescatore F, Bag R: Diffuse thallium lung uptake in Pneumocystis carinii pneumonia. Clin Nucl Med 1994;19:287-291.
35. Abdel-Dayem HM: Nuclear medicine applications in immunosuppressed patients, 'AIDS'. Ann Nucl Med 1996;10:369-373.
36. Abdel-Dayem HM, Bag R, Di Fabrizio L, Aras T, Toroglu HT, Kempf JS, Habbab N, Pescatore F, Sadik A, Kowalsky W: Evaluation of segmental thallium and gallium scans of the chest in AIDS patients. J Nucl Med 1996;37:1662-1667.
37. Turoglu HT, Akisik MF, Naddaf SY, Omar WS, Kempf JS, Abdel-Dayem HM: Tumor and infection localization in AIDS patients: Ga-67 and Tl-201 findings. Clin Nucl Med 1998;23:446-459.
38. Vanarthos WJ, Ganz WI, Vanartos JC, Serafini AN, Tehranzadeh J: Diagnostic uses of nuclear medicine in AIDS. Radiographics 1992;12:731-749.
39. Kramer EL, Ranger JJ, Garay SM, Greene JB, Tiu S, Banner H, McCauley DI: Gallium-67 scans of the chest in patients with acquired immunodeficiency syndrome. J Nucl Med 1987;28:1107-1114.
40. Lee VW, Fuller JD, O'Brien MJ, Parker DR, Cooley TP, Liebman HA: Pulmonary Kaposi sarcoma in patients with AIDS: Scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology 1991;180:409-412.
41. Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters M, Vile RG, Stewart SW: Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 2001;7:243-254.
42. 111In-DTPA-PHE-1]-octreotide. Oncology 2000;58:18-24.
43. O'Doherty MJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS: PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 1997;38:1575-1583.
44. Kulasegaram R, Saunders K, Bradbeer CS, O'Doherty M: Is there a role for positron emission tomography scanning in HIV-positive patients with Kaposi's sarcoma and lymphadenopathy: Two case reports. Int J STD AIDS 1997;8:709-712.
45. Soderlund V, Jonsson C, Bauer HC, Brosjo O, Jacobsson H: Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas. J Nucl Med 1997;38:682-686.
46. Alonso O, Martinez M, Mut F, Bruno J, Delgado L, Lago G, Nunez M, Bazzano C, Espasandin J, Touya E: Scintigraphic evaluation of malignant melanoma lesions with Tc-99m tetrofosmin. Clin Nucl Med 1998;23:683-685.
47. Schillaci O, Monteleone F, D'Andrea N, Picardi V, Cangemi R, Cangemi V, Scopinaro F: Technetium-99m tetrofosmin single photon emission computer tomography in the evaluation of suspected lung cancer. Cancer Biother Radiopharm 1999;14:129-134.
48. 99mTc- tetrofosmin scintigraphy in lung carcinoma staging and follow-up evaluations. Cancer 2002;15:1796-1807.
49. 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging. Cancer Biother Radiopharm 2000;15:81-91.
50. 99mTc-tetrofosmin SPECT in the detection of both primary breast cancer and axillary lymph node metastasis detection. Eur J Nucl Med 2001;28:1781-1794.
51. Lind P, Gallowitsch HJ, Langsteger W, Kresnik E, Mikosh P, Gomez I: Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. J Nucl Med 1997;38:348-352.
52. Arbab AS, Koizumi K, Toyama K, Araki T: Uptake of technetium-99m- tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996;37:1551-1556.
53. 99mTc-Q12 in vitro and in vivo. Nucl Med Biol 1998;25:233-240.
54. 67Ga scanning in the staging of malignant lymphoma. Success and failures. J Nucl Med 1972;13:474-475.
55. 3H]deoxyglucose in the tumor model, following chemotherapy and radiotherapy. J Nucl Med 1985;26:278-282.
56. Kaplan W: Residual mass and negative gallium scintigraphy in treated lymphoma: When is gallium scan really negative (editorial). J Nucl Med 1990;3:369-371.
57. Kostakoglu L, Yeh SDJ, Portlock C, Heelan R, Yao TJ, Niedzwieki D, Larson S: Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum. J Nucl Med 1992;33:345-350.
58. Schuster DM, Alazraki N: Gallium and other agents in diseases of the lung. Semin Nucl Med 2002;32:193-211.
59. 99mTc-tetrofosmin scintigraphy in Hodgkin's disease. Nucl Med Commun 1997;18:252-257.
60. Lee JK, Tsai SC, Ho YJ, Changlai SP, Kao CH: Technetium-99m tetrofosmin scintigraphy for detecting malignant lymphoma. Anticancer Res 2001;21:1509-1513.
61. Yang CC, Sun SS, Lin CC, Kao CH, Lee CC: Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma. Anticancer Res 2001;21:3695-3698.
62. Shiau YC, Tsai SC, Wang JJ, Ho YJ, Ho ST, Kao CH: Predicting chemotherapy response and comparing with P-glycoprotein expression using technetium-99m tetrofosmin scan in untreated malignant lymphomas. Cancer Lett 2001;170:139-146.
63. Sun SS, Tsai SC, Wang JJ, Ho YJ, Ho ST, Kao CH: Technetium-99m- tetrofosmin scintigraphy in the prediction of chemotherapy response of untreated malignant lymphomas and comparison with other prognostic factors. Anticancer Res 2001;21:685-688.
64. Liang JA, Shiau YC, Yang SN, Lin FJ, Lin CC, Kao A, Lee CC: Using technetium-99m-tetrofosmin scan to predict chemotherapy response of malignant lymphomas, compared with P-glycoprotein and multidrug resistance related protein expression. Oncol Rep 2002;9:307-312.